Next generation financing instruments for early stage biotech ventures in Europe

Friday April 16th, 10:30 – 11:00, live from the studio at the Innovation for Health event, Koen Verhoef, Head of Knowledge Transfer & Contracting…

Read more

Press Release: NLC closes second funding round of Stepping Stone Fund to finance 40 new promising HealthTech ventures

Amsterdam, Thursday 25 March 2021 – We are very pleased to announce that we’ve closed the second funding round of our Stepping Stone Fund. With…

Read more

A lot to celebrate at PEP Health with Meghan Leaver

Recently there’s been a lot to celebrate at PEP Health. The Department of International Trade listed PEP on its  ’25 to watch’ list and…

Read more

Five recommendations for optimal venture growth in your first six months!

With innovation becoming more and more important in today’s business world; the amount of aspiring entrepreneurs is growing and growing. We at NLC –…

Read more

Pressrelease: Concord Neonatal to expand sales internationally

Concord Neonatal, one of the ventures in NLC portfolio, has closed a new funding round, securing substantial funding with private investors. Concord Neonatal is…

Read more

Pressrelease: Intelligent ultrasound technique for diagnosing prostate cancer

Tilburg – 18 january 2021 – CbusineZ, the venture capital investor liaised to health insurer CZ, will together with a group of private investors,…

Read more

NLC concludes Framework Agreement with patent attorny firm De Vries & Metman

NLC  has concluded a Framework Agreement with Amsterdam based patent attorney firm De Vries & Metman for their patent and IP protection services.  “The best IP should be…

Read more

NLC’s current venture portfolio

NLC’s current venture portfolio

Read more

Inventor Brochure

Read the Inventor Brochure

Read more